DE60043062D1 - Gm-csf aus pferd - Google Patents
Gm-csf aus pferdInfo
- Publication number
- DE60043062D1 DE60043062D1 DE60043062T DE60043062T DE60043062D1 DE 60043062 D1 DE60043062 D1 DE 60043062D1 DE 60043062 T DE60043062 T DE 60043062T DE 60043062 T DE60043062 T DE 60043062T DE 60043062 D1 DE60043062 D1 DE 60043062D1
- Authority
- DE
- Germany
- Prior art keywords
- csf
- equine
- horse
- adjuvant
- subject matter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 title abstract 6
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 title abstract 6
- 241000283073 Equus caballus Species 0.000 title abstract 5
- 239000002671 adjuvant Substances 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 239000013598 vector Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13884399P | 1999-06-10 | 1999-06-10 | |
PCT/FR2000/001590 WO2000077210A1 (fr) | 1999-06-10 | 2000-06-08 | Gm-csf equin |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60043062D1 true DE60043062D1 (de) | 2009-11-12 |
Family
ID=22483915
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60043062T Expired - Lifetime DE60043062D1 (de) | 1999-06-10 | 2000-06-08 | Gm-csf aus pferd |
Country Status (14)
Country | Link |
---|---|
US (2) | US6645740B1 (de) |
EP (1) | EP1185655B1 (de) |
JP (1) | JP2003502044A (de) |
AT (1) | ATE444366T1 (de) |
AU (1) | AU781107B2 (de) |
BR (1) | BR0011469A (de) |
CA (1) | CA2375619C (de) |
CZ (1) | CZ302009B6 (de) |
DE (1) | DE60043062D1 (de) |
ES (1) | ES2333093T3 (de) |
NZ (1) | NZ515989A (de) |
PL (1) | PL205608B1 (de) |
RU (1) | RU2279476C2 (de) |
WO (1) | WO2000077210A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2823222B1 (fr) | 2001-04-06 | 2004-02-06 | Merial Sas | Vaccin contre le virus de la fievre du nil |
US20040091503A1 (en) | 2002-08-20 | 2004-05-13 | Genitrix, Llc | Lectin compositions and methods for modulating an immune response to an antigen |
MXPA05003049A (es) | 2002-09-19 | 2005-11-17 | Us Gov Health & Human Serv | Polipeptidos de phlebotomus ariasi, polipeptidos de phlebotomus perniciosus y metodos de uso. |
EP1572968B1 (de) | 2002-10-29 | 2009-04-22 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Lutzomyia longipalpis-polypeptide und verwendungsverfahren |
ES2417019T3 (es) | 2003-11-13 | 2013-08-05 | University Of Georgia Research Foundation, Inc. | Procedimiento de caracterización del virus de la enfermedad de la bursitis infecciosa |
RS51324B (sr) | 2005-04-25 | 2010-12-31 | Merial Ltd. | Vakcine protiv nipah virusa |
US7862821B2 (en) | 2006-06-01 | 2011-01-04 | Merial Limited | Recombinant vaccine against bluetongue virus |
UA100370C2 (uk) | 2006-12-11 | 2012-12-25 | Мериал Лимитед | Спосіб вакцинації птахів проти salmonella |
EP2283035B1 (de) | 2008-05-08 | 2015-07-29 | Merial Limited | Leishmania impfstoff unter verwendung von sandmücken speichelimmunogen |
US20130197612A1 (en) * | 2010-02-26 | 2013-08-01 | Jack W. Lasersohn | Electromagnetic Radiation Therapy |
LT2734230T (lt) | 2011-07-20 | 2019-03-25 | Merial Limited | Rekombinantinė kačių leikemijos viruso vakcina, turinti optimizuotą kačių leukemijos viruso apvalkalo geną |
CA2867893C (en) | 2012-03-20 | 2022-09-20 | Merial Limited | Recombinant equine herpesvirus-1 vaccine containing mutated glycoprotein c and uses thereof |
AP2015008331A0 (en) | 2012-08-30 | 2015-03-31 | Top Ind Sas | Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5162111A (en) * | 1986-07-30 | 1992-11-10 | Grabstein Kenneth H | Treatment of bacterial diseases with granulocyte-macrophage colony stimulating factor |
WO1992005255A1 (en) | 1990-09-13 | 1992-04-02 | Commonwealth Scientific And Industrial Research Organisation | Ovine cytokine genes |
WO1994001133A1 (en) | 1992-07-08 | 1994-01-20 | Schering Corporation | Use of gm-csf as a vaccine adjuvant |
AUPM543894A0 (en) * | 1994-05-04 | 1994-05-26 | Commonwealth Scientific And Industrial Research Organisation | An adjuvant |
FR2751226B1 (fr) | 1996-07-19 | 1998-11-27 | Rhone Merieux | Formule de vaccin polynucleotidique contre les pathologies du cheval |
-
2000
- 2000-06-07 US US09/589,460 patent/US6645740B1/en not_active Expired - Lifetime
- 2000-06-08 AU AU55403/00A patent/AU781107B2/en not_active Expired
- 2000-06-08 AT AT00940472T patent/ATE444366T1/de not_active IP Right Cessation
- 2000-06-08 NZ NZ515989A patent/NZ515989A/xx not_active IP Right Cessation
- 2000-06-08 WO PCT/FR2000/001590 patent/WO2000077210A1/fr active Application Filing
- 2000-06-08 ES ES00940472T patent/ES2333093T3/es not_active Expired - Lifetime
- 2000-06-08 JP JP2001503654A patent/JP2003502044A/ja active Pending
- 2000-06-08 DE DE60043062T patent/DE60043062D1/de not_active Expired - Lifetime
- 2000-06-08 BR BR0011469-3A patent/BR0011469A/pt not_active Application Discontinuation
- 2000-06-08 EP EP00940472A patent/EP1185655B1/de not_active Expired - Lifetime
- 2000-06-08 RU RU2002100209/13A patent/RU2279476C2/ru active
- 2000-06-08 CA CA2375619A patent/CA2375619C/en not_active Expired - Lifetime
- 2000-06-08 PL PL352484A patent/PL205608B1/pl unknown
- 2000-06-08 CZ CZ20014377A patent/CZ302009B6/cs not_active IP Right Cessation
-
2003
- 2003-07-07 US US10/614,481 patent/US7250161B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US20050059121A1 (en) | 2005-03-17 |
NZ515989A (en) | 2003-06-30 |
RU2279476C2 (ru) | 2006-07-10 |
US7250161B2 (en) | 2007-07-31 |
AU781107B2 (en) | 2005-05-05 |
CZ302009B6 (cs) | 2010-09-01 |
AU5540300A (en) | 2001-01-02 |
US6645740B1 (en) | 2003-11-11 |
CA2375619A1 (en) | 2000-12-21 |
EP1185655A1 (de) | 2002-03-13 |
ES2333093T3 (es) | 2010-02-17 |
JP2003502044A (ja) | 2003-01-21 |
CZ20014377A3 (cs) | 2002-04-17 |
EP1185655B1 (de) | 2009-09-30 |
PL352484A1 (en) | 2003-08-25 |
WO2000077210A1 (fr) | 2000-12-21 |
ATE444366T1 (de) | 2009-10-15 |
BR0011469A (pt) | 2002-03-05 |
PL205608B1 (pl) | 2010-05-31 |
CA2375619C (en) | 2013-01-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60043062D1 (de) | Gm-csf aus pferd | |
ATE477224T1 (de) | Verwendung von miniatursierten vorrichtungen zur herstellung von radiomarkierten verbindungen | |
ATE469911T1 (de) | Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung | |
NO20031129D0 (no) | Varianter av human koagulasjonsfaktor VII | |
ATE398676T2 (de) | Antagonistische selektive bindungsagenzien des osteoprotegerin-bindungsproteins | |
ATE384072T1 (de) | Modulation der immunostimulatorischen aktivität von immunostimulierenden oligonukleotidanaloga durch positionelle chemische veränderungen | |
YU9403A (sh) | Anti-dualna antitela integrina, kompozicije, postupci i primene | |
DK1266011T3 (da) | Svampetranskriptionsaktivator, der er anvendelig i fremgangsmåder til fremstilling af polypeptider | |
UA91180C2 (ru) | Клетка бактерий mycobacterium bovis, которая является уреазодефицитной, и применение данной клетки для изготовления живой вакцины против туберкулеза | |
DK1675956T3 (da) | Minimal DNA-sekvens, der virksom som chromatinisolator, og dennes anvendelse til proteinekspression | |
WO1999061618A3 (en) | Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof | |
MXPA00002111A (es) | Biomoleculas que contienen un peptido elastomerico. | |
AU7303301A (en) | Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof | |
ATE340257T1 (de) | Histonedeacetylase 9 | |
WO1999047558A3 (en) | T cell costimulatory proteins, sequences and uses thereof | |
DE60139959D1 (de) | Nukleinsäureadjuvantien | |
DK1279677T3 (da) | GD3-mimetiske peptider | |
AR022150A1 (es) | Acidos nucleicos derivados de monocitos y composiciones y metodos relacionados | |
NO972353L (no) | Nye polypeptider | |
DE69836485D1 (de) | Hepatitis e-virus aus dem schwein und dessen verwendungen | |
DK1005532T3 (da) | Isolerede nukleinsyremolekyler kodende for SSX familiemedlemmer og anvendelser deraf | |
ATE307201T1 (de) | Srcr domäne-enthaltendes protein | |
MX2022015376A (es) | Construcciones anti grupo de diferenciacion 93 (cd93) y usos de las mismas. | |
MXPA02008731A (es) | Proteina de membrana exterior de rickettsia felis. | |
SE0100412D0 (sv) | Novel human poly(A) polymerase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |